MLP3 LLC’s Eli Lilly LLY Stock Holding History

MLP3 LLC’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$216K	Sell	235 -20	-8%	-$20.3K	0.24%	82
2025 Q4	$274K	Buy	+255	New	+$244K	0.3%	66

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MLP3 LLC's LLY Position: Q1 2026 in Review

MLP3 LLC reduced its Eli Lilly (LLY) stake by 7.8% in Q1 2026, selling an estimated $20.3K and leaving 235 shares worth $216K. The position accounts for 0.24% of the portfolio, ranked #82.

MLP3 LLC first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $274K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

MLP3 LLC held 235 shares of Eli Lilly worth $216K as of Q1 2026.
MLP3 LLC sold 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
Eli Lilly made up 0.24% of MLP3 LLC's portfolio in Q1 2026, its #82 holding.
MLP3 LLC first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
MLP3 LLC's Eli Lilly position peaked at $274K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on MLP3 LLC's 13F filing for Q1 2026, filed 13 Apr 2026.